• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓与动脉血栓之间的联系:内皮功能障碍是否起作用?

The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?

作者信息

Donadini Marco Paolo, Calcaterra Francesca, Romualdi Erica, Ciceri Roberta, Cancellara Assunta, Lodigiani Corrado, Bacci Monica, Della Bella Silvia, Ageno Walter, Mavilio Domenico

机构信息

Department of Medicine and Surgery, Research Center on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, 21100 Varese, Italy.

Centro Trombosi e TAO, Azienda Socio Sanitaria Territoriale dei Sette Laghi, 21100 Varese, Italy.

出版信息

Cells. 2025 Jan 20;14(2):144. doi: 10.3390/cells14020144.

DOI:10.3390/cells14020144
PMID:39851572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11763525/
Abstract

Venous thromboembolism (VTE) and arterial thrombosis (AT) are distinct yet closely related pathological processes. While traditionally considered separate entities, accumulating evidence suggests that they share common risk factors, such as inflammation and endothelial dysfunction (ED). This review explores the parallels and differences between venous and arterial thrombosis, with particular attention to the role of unprovoked VTE and its potential links to atherosclerosis and systemic inflammation. A key focus is the role of ED, which is emerging as a critical factor in thrombogenesis across both the venous and arterial systems. We examine the current methods for clinically detecting ED, including the use of biomarkers and advanced imaging techniques. Additionally, we discuss novel research avenues, such as the potential of endothelial colony-forming cells and other innovative methodologies, to further unravel the complex mechanisms of thrombosis. Finally, we propose future clinical scenarios where targeting endothelial health could pave the way for more effective prevention and treatment strategies in thrombosis management.

摘要

静脉血栓栓塞症(VTE)和动脉血栓形成(AT)是不同但密切相关的病理过程。虽然传统上认为它们是独立的实体,但越来越多的证据表明它们有共同的危险因素,如炎症和内皮功能障碍(ED)。本综述探讨了静脉血栓形成和动脉血栓形成之间的异同,特别关注不明原因VTE的作用及其与动脉粥样硬化和全身炎症的潜在联系。一个关键重点是ED的作用,它正成为静脉和动脉系统血栓形成的关键因素。我们研究了目前临床上检测ED的方法,包括生物标志物的使用和先进的成像技术。此外,我们还讨论了新的研究途径,如内皮祖细胞的潜力和其他创新方法,以进一步揭示血栓形成的复杂机制。最后,我们提出了未来的临床设想,即针对内皮健康可能为血栓形成管理中更有效的预防和治疗策略铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1e/11763525/10ffb134fe88/cells-14-00144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1e/11763525/10ffb134fe88/cells-14-00144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1e/11763525/10ffb134fe88/cells-14-00144-g001.jpg

相似文献

1
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?静脉血栓与动脉血栓之间的联系:内皮功能障碍是否起作用?
Cells. 2025 Jan 20;14(2):144. doi: 10.3390/cells14020144.
2
Is there a link between venous and arterial thrombosis? A reappraisal.静脉血栓与动脉血栓之间存在关联吗?一项重新评估。
Intern Emerg Med. 2020 Jan;15(1):33-36. doi: 10.1007/s11739-019-02238-6. Epub 2019 Nov 26.
3
Arterial and venous thrombosis: What's the link? A narrative review.动脉和静脉血栓形成:它们之间有联系吗?一篇叙述性综述。
Thromb Res. 2020 Jul;191:97-102. doi: 10.1016/j.thromres.2020.04.035. Epub 2020 Apr 27.
4
The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis.炎症在静脉血栓栓塞中的作用以及动脉血栓形成与静脉血栓形成之间的联系。
Int Angiol. 2007 Dec;26(4):306-11.
5
Advances in understanding the molecular mechanisms of venous thrombosis.理解静脉血栓形成分子机制的研究进展。
Br J Haematol. 2019 Jul;186(1):13-23. doi: 10.1111/bjh.15869. Epub 2019 Mar 24.
6
Endothelium, venous thromboembolism and ischaemic cardiovascular events.内皮细胞、静脉血栓栓塞和缺血性心血管事件。
Thromb Haemost. 2010 Jan;103(1):56-61. doi: 10.1160/TH09-08-0562. Epub 2009 Nov 13.
7
Microparticles as biomarkers of venous thromboembolic events.作为静脉血栓栓塞事件生物标志物的微粒
Biomark Med. 2016 Jul;10(7):743-55. doi: 10.2217/bmm-2015-0063. Epub 2016 Jun 24.
8
Venous thrombosis and obesity: from clinical needs to therapeutic challenges.静脉血栓形成与肥胖:从临床需求到治疗挑战
Intern Emerg Med. 2025 Jan;20(1):47-64. doi: 10.1007/s11739-024-03765-7. Epub 2024 Sep 13.
9
Extent of flow recirculation governs expression of atherosclerotic and thrombotic biomarkers in arterial bifurcations.血流再循环的程度决定了动脉分叉处动脉粥样硬化和血栓形成生物标志物的表达。
Cardiovasc Res. 2014 Jul 1;103(1):37-46. doi: 10.1093/cvr/cvu124. Epub 2014 May 19.
10
Varied response of the pulmonary arterial endothelium in a novel rat model of venous thromboembolism.新型大鼠静脉血栓栓塞模型中肺动脉内皮细胞的多样化反应。
Chin Med J (Engl). 2013 Jan;126(1):114-7.

引用本文的文献

1
Factor XI and Cancer: Physiopathological Linkage and Clinical Perspectives.凝血因子XI与癌症:生理病理联系及临床展望
J Clin Med. 2025 Sep 8;14(17):6341. doi: 10.3390/jcm14176341.
2
Reprogramming Atherosclerosis: Precision Drug Delivery, Nanomedicine, and Immune-Targeted Therapies for Cardiovascular Risk Reduction.重塑动脉粥样硬化:精准药物递送、纳米医学与免疫靶向疗法以降低心血管风险
Pharmaceutics. 2025 Aug 7;17(8):1028. doi: 10.3390/pharmaceutics17081028.
3
Advanced Research in the Pathophysiology of Venous Thromboembolism-Acute Pulmonary Embolism.

本文引用的文献

1
Risk of Venous Thromboembolism in Statin Users Compared to Fibrate Users in the United Kingdom Clinical Practice Research Datalink (UK CPRD) GOLD.在英国临床实践研究数据链(UK CPRD)GOLD中,他汀类药物使用者与贝特类药物使用者相比发生静脉血栓栓塞的风险。
Clin Epidemiol. 2024 Oct 5;16:683-697. doi: 10.2147/CLEP.S481448. eCollection 2024.
2
Thromboinflammation in COVID-19: Unraveling the interplay of coagulation and inflammation.新型冠状病毒肺炎中的血栓炎症反应:解析凝血与炎症的相互作用。
Medicine (Baltimore). 2024 Jul 12;103(28):e38922. doi: 10.1097/MD.0000000000038922.
3
Factor VIII promotes angiogenesis and vessel stability regulating extracellular matrix proteins.
静脉血栓栓塞症-急性肺栓塞病理生理学的前沿研究
Biomedicines. 2025 Apr 8;13(4):906. doi: 10.3390/biomedicines13040906.
4
Targeted drug delivery systems for atherosclerosis.用于动脉粥样硬化的靶向给药系统。
J Nanobiotechnology. 2025 Apr 23;23(1):306. doi: 10.1186/s12951-025-03384-0.
5
How Advanced Is Nanomedicine for Atherosclerosis?纳米医学在动脉粥样硬化治疗方面有多先进?
Int J Nanomedicine. 2025 Mar 17;20:3445-3470. doi: 10.2147/IJN.S508757. eCollection 2025.
凝血因子VIII通过调节细胞外基质蛋白促进血管生成和血管稳定性。
Haematologica. 2024 Oct 1;109(10):3391-3397. doi: 10.3324/haematol.2024.285089.
4
Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.抗炎治疗与已患有心血管疾病或心血管风险高的患者心肌梗死风险降低相关:一项随机对照试验的系统评价和荟萃分析。
Atherosclerosis. 2023 Aug;379:117181. doi: 10.1016/j.atherosclerosis.2023.06.972. Epub 2023 Jul 6.
5
Development of Personalized Thrombogenesis and Thrombin Generation Assays to Assess Endothelial Dysfunction in Cardiovascular Diseases.用于评估心血管疾病中内皮功能障碍的个性化血栓形成和凝血酶生成检测方法的开发。
Biomedicines. 2023 Jun 8;11(6):1669. doi: 10.3390/biomedicines11061669.
6
Novel vascular roles of human endoglin in pathophysiology.人类内皮糖蛋白在病理生理学中的新型血管作用。
J Thromb Haemost. 2023 Sep;21(9):2327-2338. doi: 10.1016/j.jtha.2023.06.007. Epub 2023 Jun 12.
7
Soluble endoglin reduces thrombus formation and platelet aggregation via interaction with αIIbβ3 integrin.可溶性内皮糖蛋白通过与 αIIbβ3 整合素相互作用减少血栓形成和血小板聚集。
J Thromb Haemost. 2023 Jul;21(7):1943-1956. doi: 10.1016/j.jtha.2023.03.023. Epub 2023 Mar 28.
8
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1).纤溶酶原激活物抑制剂 1(PAI-1)的过去、现在和未来展望。
Semin Thromb Hemost. 2023 Apr;49(3):305-313. doi: 10.1055/s-0042-1758791. Epub 2022 Dec 15.
9
Novel insights on the role of VCAM-1 and ICAM-1: Potential biomarkers for cardiovascular diseases.关于血管细胞粘附分子-1(VCAM-1)和细胞间粘附分子-1(ICAM-1)作用的新见解:心血管疾病的潜在生物标志物
Ann Med Surg (Lond). 2022 Oct 31;84:104802. doi: 10.1016/j.amsu.2022.104802. eCollection 2022 Dec.
10
Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine.评估血管功能的方法:迈向预测性、预防性和个性化医学的关键途径。
EPMA J. 2022 May 20;13(2):209-235. doi: 10.1007/s13167-022-00280-7. eCollection 2022 Jun.